The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Rb Regulates DNA Damage Response and Cellular Senescence through E2F-Dependent Suppression of N-Ras Isoprenylation
Open accessAbstract
Oncogene-induced cellular senescence is well documented, but little is known about how infinite cell proliferation induced by loss of tumor suppressor genes is antagonized by cellular functions. Rb heterozygous mice generate Rb-deficient C cell adenomas that progress to adenocarcinomas following biallelic loss of N-ras. Here, we demonstrate that pRb inactivation induces aberrant expression of farnesyl diphosphate synthase, many prenyltransferases, and their upstream regulators sterol regulatory element-binding proteins (SREBPs) in an E2F-dependent manner, leading to enhanced isoprenylation and activation of N-Ras. Consequently, elevated N-Ras activity induces DNA damage response and p130-dependent cellular senescence in Rb-deficient cells. Furthermore, Rb heterozygous mice additionally lacking any of Ink4a, Arf, or Suv39h1 generated C cell adenocarcinomas, suggesting that cellular senescence antagonizes Rb-deficient carcinogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The loss of tumour suppressors, such as PTEN 23 (BOX 2), RB 27 , neurofribromin 1 (NF1) 28 and inositol polyphosphate-4-phosphatase, type II (INPP4B) 29 , has also been associated with senescence in premalignant tumours.”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [27]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Todaro, G. J., & Green, H. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.2.299 · Cited by 2,747
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 2×
“We also detected senescence-associated heterochromatin foci (SAHF) (Narita et al., 2003) (Figure 3D) and high SA-b-gal activity (Figure 3F).”
BackgroundCrucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability
Peters, A. H. F. M., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00542-6 · Cited by 1,766
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Cited by
Sorted by citations
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Santos, C. R., & Schulze, A. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08644.x · Cited by 1,371
Cellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology
Shimano, H., & Sato, R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.91 · Cited by 1,174
Senescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124
Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer
Snaebjornsson, M. T., Janaki-Raman, S., & Schulze, A. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.010 · Cited by 1,097
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Schulze, A., & Harris, A. L. (2012) · Nature · doi:10.1038/nature11706 · Cited by 945
Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression
Li, Z., & Zhang, H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2070-4 · Cited by 840
Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development
Baenke, F., Peck, B., Miess, H., & Schulze, A. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011338 · Cited by 772
The interplay between cell signalling and the mevalonate pathway in cancer
Mullen, P., Yu, R., Longo, J., Archer, M. C., & Penn, L. Z. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.76 · Cited by 714
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.013 · Cited by 589
Phan, L. M., Yeung, S. J., & Lee, M. H. (2014) · Europe PMC (PubMed Central) · doi:10.7497/j.issn.2095-3941.2014.01.001 · Cited by 512
Inside and out: the activities of senescence in cancer
Pérez-Mancera, P. A., Young, A. R. J., & Narita, M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3773 · Cited by 462
Pro-senescence therapy for cancer treatment
Nardella, C., Clohessy, J. G., Alimonti, A., & Pandolfi, P. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3057 · Cited by 437
Senescence-associated inflammatory responses: aging and cancer perspectives
Lasry, A., & Ben-Neriah, Y. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.009 · Cited by 408
Healing and Hurting: Molecular Mechanisms, Functions, and Pathologies of Cellular Senescence
Adams, P. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.021 · Cited by 326
The fat side of prostate cancer
Zadra, G., Photopoulos, C., & Loda, M. F. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.03.010 · Cited by 301
Henley, S. A., & Dick, F. A. (2012) · Cell Division · doi:10.1186/1747-1028-7-10 · Cited by 296
Oncogene-induced senescence: the bright and dark side of the response
Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.07.013 · Cited by 257
Senescence: a new weapon for cancer therapy
Acosta, J. C., & Gil, J. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.11.006 · Cited by 235
Zebrafish Models of Cancer—New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate
Hason, M., & Bartůněk, P. (2019) · Genes · doi:10.3390/genes10110935 · Cited by 219
Cellular senescence in cancer: from mechanisms to detection
Ou, H., Hoffmann, R. J., González‐López, C., Doherty, G. J., Korkola, J. E., & Muñoz‐Espín, D. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12807 · Cited by 208
The Mevalonate Pathway, a Metabolic Target in Cancer Therapy
Guerra, B., Recio, C., Aranda-Tavío, H., Guerra-Rodríguez, M., García-Castellano, J. M., & Fernández‐Pérez, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.626971 · Cited by 177
SCAP/SREBPs are Central Players in Lipid Metabolism and Novel Metabolic Targets in Cancer Therapy
Cheng, X., Li, J., & Guo, D. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180523104541 · Cited by 139
Prieur, A., Besnard, E., Babled, A., & Lemaitre, J.-M. (2011) · Nature Communications · doi:10.1038/ncomms1473 · Cited by 117
Lunyak, V. V., Amaro-Ortiz, A., & Gaur, M. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00220 · Cited by 119
To clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · BioEssays · doi:10.1002/bies.201670910 · Cited by 108
Regulation of senescence and the SASP by the transcription factor C/EBPβ
Salotti, J., & Johnson, P. F. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110752 · Cited by 103
Regulation of Cancer Metabolism by Oncogenes and Tumor Suppressors
Iurlaro, R., León‐Annicchiarico, C. L., & Muñoz‐Pinedo, C. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00003-0 · Cited by 114
Emerging roles of RB family: New defense mechanisms against tumor progression
Indovina, P., Marcelli, E., Casini, N., Rizzo, V., & Giordano, A. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24170 · Cited by 95
Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer
Mitri, D. D., & Alimonti, A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.005 · Cited by 92
Kaymak, I., Maier, C. R., Schmitz, W., Campbell, A. D., Dankworth, B., Ade, C. P., Walz, S., Paauwe, M., Kalogirou, C., Marouf, H., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0650 · Cited by 90
Exploiting tumor cell senescence in anticancer therapy
Lee, M., & Lee, J. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.2.005 · Cited by 85
Caveolin-1, a master regulator of cellular senescence
Volonté, D., & Galbiati, F. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09875-w · Cited by 79
Linn, P., Kohno, S., Sheng, J., Kulathunga, N., Yu, H., Zhang, Z., Voon, D. C., Watanabe, Y., & Takahashi, C. (2021) · Cancers · doi:10.3390/cancers13153737 · Cited by 70
Self-citationTranscriptional control of stem cell fate by E2Fs and pocket proteins
Julian, L. M., & Blais, A. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00161 · Cited by 71
Lee‐Rueckert, M., Canyelles, M., Tondo, M., Rotllán, N., Kovanen, P. T., Llorente‐Cortés, V., & Escolá‐Gil, J. C. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.05.002 · Cited by 68
Cell cycle dependence on the mevalonate pathway: Role of cholesterol and non-sterol isoprenoids
Lasunción, M. A., Martínez-Botas, J., Martín-Sánchez, C., Busto, R., & Gómez‐Coronado, D. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114623 · Cited by 62
The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins
Mo, H., Jeter, R., Bachmann, A., Yount, S. T., Shen, C., & Yeganehjoo, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01515 · Cited by 56
Shang, J., Yao, Y., Fan, X., Shangguan, L., Li, J., Liu, H., & Zhou, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.005 · Cited by 59
How cancer cells remodel lipid metabolism: strategies targeting transcription factors
Jeong, D., Lee, S., & Chun, Y. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01593-8 · Cited by 57
Kitajima, S., Yoshida, A., Kohno, S., Li, F., Suzuki, S., Nagatani, N., Nishimoto, Y., Sasaki, N., Muranaka, H., Wan, Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.124 · Cited by 52
Self-citationCholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions
Laka, K., Makgoo, L., & Mbita, Z. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.841639 · Cited by 51
Modified aging of elite athletes revealed by analysis of epigenetic age markers
Spólnicka, M., Pośpiech, E., Adamczyk, J. G., Freire-Aradas, A., Pepłońska, B., Zbieć-Piekarska, R., Makowska, Ż., Pięta, A., Lareu, M. V., Phillips, C., et al. (2018) · Aging · doi:10.18632/aging.101385 · Cited by 52
Intersection of retinoblastoma tumor suppressor function, stem cells, metabolism, and inflammation
Kitajima, S., & Takahashi, C. (2017) · Cancer Science · doi:10.1111/cas.13312 · Cited by 50
Self-citationp53 attenuates AKT signaling by modulating membrane phospholipid composition
Rueda-Rincón, N., Bloch, K. M., Derua, R., Vyas, R., Harms, A. C., Hankemeier, T., Khan, N. A., Dehairs, J., Bagadi, M., Binda, M. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4067 · Cited by 48
ATM Mediates pRB Function To Control DNMT1 Protein Stability and DNA Methylation
Shamma, A., Suzuki, M., Hayashi, N., Kobayashi, M., Sasaki, N., Nishiuchi, T., Doki, Y., Okamoto, T., Kohno, S., Muranaka, H., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01597-12 · Cited by 45
Self-citationWang, J., Shao, F., Yu, Q., Ye, L., Wusiman, D., Wu, R., Tuo, Z., Wang, Z., Li, D., Cho, W. C. S., et al. (2025) · Research · doi:10.34133/research.0612 · Cited by 45
Characterization of the Oncogenic Activity of the Novel TRIM59 Gene in Mouse Cancer Models
Valiyeva, F., Jiang, F., Elmaadawi, A. Z., Moussa, M., Yee, S., Raptis, L. H., Izawa, J. I., Yang, B. B., Greenberg, N. M., Wang, F., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0077 · Cited by 41
USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer
Maier, C. R., Hartmann, O., Prieto‐Garcia, C., Al-Shami, K. M., Schlicker, L., Vogel, F. C. E., Haid, S., Klann, K., Buck, V., Münch, C., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01173-6 · Cited by 40
Qian, P., Han, B., Forestier, E. C. F., Hu, Z., Gao, N., Lu, W., Schaller, H., Li, J., & Hou, S. (2013) · The Plant Journal · doi:10.1111/tpj.12190 · Cited by 40
Disruption of Tacc3 function leads to in vivo tumor regression
Yao, R., Natsume, Y., Saiki, Y., Shioya, H., Takeuchi, K., Yamori, T., Toki, H., Aoki, I., Saga, T., & Noda, T. (2011) · Oncogene · doi:10.1038/onc.2011.235 · Cited by 40
Yao, R., Kondoh, Y., Natsume, Y., Yamanaka, H., Inoue, M., Toki, H., Takagi, R., Shimizu, T., Yamori, T., Osada, H., et al. (2013) · Oncogene · doi:10.1038/onc.2013.382 · Cited by 36
Senescence and pre-malignancy: How do tumors progress?
Saab, R. H. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.013 · Cited by 38
Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma
Macià, A., Gallel, P., Vaquero, M., Gou-Fàbregas, M., Santacana, M., Maliszewska, A., Robledo, M., Gardiner, J. R., Basson, M. A., Matías‐Guiu, X., et al. (2011) · Oncogene · doi:10.1038/onc.2011.556 · Cited by 37
The Role of Hypoxia Inducible Factor-1 Alpha in Bypassing Oncogene-Induced Senescence
Eren, M. K., & Tabor, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101064 · Cited by 35
Fang, Y., Hu, X., Jia, Z., Xu, M., Zhu-ying, G., & Gao, F. (2012) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2012.00912.x · Cited by 35
Malavolta, M., Costarelli, L., Giacconi, R., Piacenza, F., Basso, A., Pierpaoli, E., Marchegiani, F., Cardelli, M., Provinciali, M., & Mocchegiani, E. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.02.006 · Cited by 35
Muranaka, H., Hayashi, A., Minami, K., Kitajima, S., Kohno, S., Nishimoto, Y., Nagatani, N., Suzuki, M., Kulathunga, L. A. N., Sasaki, N., et al. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.51 · Cited by 34
Self-citationChen, Z., Chen, G., & Zhao, H. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15542 · Cited by 34
Pesch, A. M., Hirsh, N. H., Michmerhuizen, A. R., Jungles, K. M., Wilder-Romans, K., Chandler, B. C., Liu, M., Lerner, L. M., Nino, C. A., Ward, C., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.154402 · Cited by 33
Tang, Q., Liang, B., Zhang, L., Li, X., Li, H., Jing, W., Jiang, Y., Zhou, F., Zhang, J., Meng, Y., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-22410-x · Cited by 33
ASPP2 inhibits tumor growth by repressing the mevalonate pathway in hepatocellular carcinoma
Liang, B., Chen, R., Song, S., Wang, H., Sun, G., Yang, H., Jing, W., Zhou, X., Fu, Z., Huang, G., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2054-7 · Cited by 33
The Histone Methyltransferase SUV39H1 Suppresses Embryonal Rhabdomyosarcoma Formation in Zebrafish
Albacker, C. E., Storer, N. Y., Langdon, E. M., DiBiase, A., Zhou, Y., Langenau, D. M., & Zon, L. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064969 · Cited by 34
Kitajima, S., Miki, T., Takegami, Y., Kido, Y., Noda, M., Hara, E., Shamma, A., & Takahashi, C. (2010) · Oncogene · doi:10.1038/onc.2010.448 · Cited by 33
Self-citationTumor Milieu Controlled by RB Tumor Suppressor
Kitajima, S., Li, F., & Takahashi, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072450 · Cited by 30
Self-citationFu, C., Li, B., Sun, Y., Ma, G., & Yao, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.5071 · Cited by 30
The β1-Integrin–Dependent Function of RECK in Physiologic and Tumor Angiogenesis
Miki, T., Shamma, A., Kitajima, S., Takegami, Y., Noda, M., Nakashima, Y., Watanabe, K.-I., & Takahashi, C. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0351 · Cited by 30
Self-citationTwists in views on RB functions in cellular signaling, metabolism and stem cells
Takahashi, C., Sasaki, N., & Kitajima, S. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02284.x · Cited by 29
Self-citationJohnson, B. A., Aloor, H. L., & Moody, C. A. (2016) · Virology · doi:10.1016/j.virol.2016.09.029 · Cited by 32
Báez, R. V. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73796 · Cited by 27
Metabolomics and cellular altered pathways in cancer biology: A review
Bhardwaj, J. K., Siwach, A., & Sachdeva, S. N. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23807 · Cited by 27
Senescent Cells in Cancer: Wanted or Unwanted Citizens
Niklander, S. E., Lambert, D., & Hunter, K. D. (2021) · Cells · doi:10.3390/cells10123315 · Cited by 28
The switch from pRb/p105 to Rb2/p130 in DNA damage and cellular senescence
Helmbold, H., Galderisi, U., & Bohn, W. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22786 · Cited by 25
Drug-induced premature senescence model in human dental follicle stem cells
Zhai, Y., Wei, R., Liu, J., Wang, H., Cai, W., Zhao, M., Hu, Y., Wang, S., Yang, T., Liu, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14085 · Cited by 26
Kitajima, S., Kohno, S., Kondoh, A., Sasaki, N., Nishimoto, Y., Li, F., Mohammed, M. S. A., Muranaka, H., Nagatani, N., Suzuki, M., et al. (2015) · Stem Cells · doi:10.1002/stem.1971 · Cited by 24
Self-citationAutophagy and senescence, converging roles in pathophysiology as seen through mouse models
Young, A. R. J., Cassidy, L. D., & Narita, M. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.02.001 · Cited by 22
Lipid metabolic pathways as lung cancer therapeutic targets: A computational study
Yano, K. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.876 · Cited by 20
Cellular senescence in vivo: From cells to tissues to pathologies
Kumar, A., Bano, D., & Ehninger, D. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111308 · Cited by 19
Kellers, F., Fernandez, A., Konukiewitz, B., Schindeldecker, M., Tagscherer, K. E., Heintz, A., Jesinghaus, M., Roth, W., & Foersch, S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.865230 · Cited by 20
Epigenetic mechanisms in senescence, immortalisation and cancer
Carnero, A., & LLeonart, M. E. (2010) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2010.00154.x · Cited by 19
Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies
Kohno, S., Kitajima, S., Sasaki, N., & Takahashi, C. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i4.170 · Cited by 18
Self-citationSenescence, oxidative stress and mitochondria dysfunction
Zhu, M.-J., Wang, X., Shi, L., Liang, L., & Wang, Y. (2018) · Medical Research and Innovations · doi:10.15761/mri.1000149 · Cited by 19
Lipid Metabolism in Cancer Cells
Zheng, M., Wang, W., Liu, J., Zhang, X., & Zhang, R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6785-2_4 · Cited by 19
RB functions as a key regulator of senescence and tumor suppression
Gao, M., Li, H., & Zhang, J. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.11.004 · Cited by 17
Ko, T., Sharma, R., & Li, S. (2019) · Oncogene · doi:10.1038/s41388-019-1022-0 · Cited by 18
Ji, Y., Wang, Q., Zhao, Q., Zhao, S., Li, L., Sun, G., & Ye, L. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10148-y · Cited by 16
Succoio, M., Comegna, M., DˈAmbrosio, C., Scaloni, A., Cimino, F., & Faraonio, R. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.07.010 · Cited by 16
Dean, J. L., McClendon, A. K., Stengel, K. R., & Knudsen, E. S. (2009) · Oncogene · doi:10.1038/onc.2009.313 · Cited by 15
Babu, V. S., Mallipatna, A. C., Deepak, S. A., Dudeja, G., Kannan, R., Shetty, R., Nair, A. P., Gundimeda, S., Chaurasia, S. S., Verma, N. K., et al. (2022) · Cells · doi:10.3390/cells11101668 · Cited by 17
Sen, M., Akeno, N., Reece, A. L., Miller, A. L., Simpson, D. S., & Wikenheiser‐Brokamp, K. A. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.5 · Cited by 15
Zhang, S., Cheng, Z., Yu, J., Lǚ, K., Xu, S., Lü, Y., Liu, T., Xia, B., Huang, Z. L., Zhao, X., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.4209 · Cited by 12
Lim, J. Y., & Kwan, H. Y. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80788 · Cited by 12
Winkelkotte, A. M., Al-Shami, K. M., Chaves‐Filho, A. B., Vogel, F. C. E., & Schulze, A. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041548 · Cited by 15
Research progress of SREBP and its role in the pathogenesis of autoimmune rheumatic diseases
Xu, X., Jin, W., Chang, R., & Ding, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1398921 · Cited by 12
Statin as a therapeutic agent in gastroenterological cancer
Uemura, N., Hayashi, H., & Baba, H. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i1.110 · Cited by 11
Therapeutic, diagnostic and prognostic values of TRIM proteins in prostate cancer
Li, X., Bai, Y., Feng, K., Chu, Z., Li, H., Lin, Z., & Lin, T. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00534-9 · Cited by 9
Oturkar, C. C., Rosario, S. R., Hutson, A. D., Groman, A., Edge, S. B., Morrison, C. D., Swetzig, W. M., Wang, J., Park, J. H., Kaipparettu, B. A., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109995 · Cited by 7
To clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · Inside the Cell · doi:10.1002/icl3.1046 · Cited by 8
Metadata
- Authors
- Shamma, A., Takegami, Y., Miki, T., Kitajima, S., Noda, M., Obara, T., Okamoto, T., & Takahashi, C.
- Affiliations
- Kyoto University (JP)
- Tokyo Women's Medical University (JP)
- Corresponding author
- Takahashi, Chiaki
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 15
- Issue
- 4
- Pages
- 255-269
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2122846804
- Cited by
- 140
- References
- 63
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 8 · 2023: 5 · 2022: 6 · 2021: 14 · 2020: 10 · 2019: 12 · 2018: 5 · 2017: 7 · 2016: 10 · 2015: 11 · 2014: 11 · 2013: 9 · 2012: 7
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) (submittedVersion, cc-by-nc-nd)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion)
- Funders
- Princess Takamatsu Cancer Research Fund
- Takeda Science Foundation
- Ministry of Education, Culture, Sports, Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- retinoblastoma protein, oncogene-induced senescence, NRAS, isoprenylation, DNA damage response, E2F transcription factors, farnesyl diphosphate synthase, prenyltransferase, SREBP, p130, INK4A, ARF, SUV39H1, tumor suppressor inactivation, carcinogenesis
- MeSH terms
- Adenocarcinoma, Adenoma, Animals, Cell Membrane, DNA Damage, DNA Repair, Humans, Immunoenzyme Techniques, Genes, ras, Thyroid Neoplasms, Retinoblastoma Protein, Cellular Senescence, Protein Prenylation, Mice, Knockout, Cyclin-Dependent Kinase Inhibitor p16, Brain Stem Neoplasms, Protein Transport, Chromatin Immunoprecipitation, E2F Transcription Factors, Mice, Prenylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review